BSW Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
BSW Wealth Partners's NVO Position: Q3 2025 in Review
BSW Wealth Partners sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 9,099 shares — an estimated $628K sold.
BSW Wealth Partners first reported a position in NVO in Q3 2020 and held it in 14 quarters. The position peaked at $1.24M in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.
- BSW Wealth Partners reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
- BSW Wealth Partners sold 9,099 Novo Nordisk shares in Q3 2025, an estimated $628K.
- BSW Wealth Partners first reported a position in Novo Nordisk in Q3 2020 and held it in 14 quarters.
- BSW Wealth Partners's Novo Nordisk position peaked at $1.24M in Q2 2024.
- 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.
Based on BSW Wealth Partners's 13F filing for Q3 2025, filed 15 Oct 2025.